These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2897198)

  • 21. Cysteine and glutathione deficiency in AIDS patients: a rationale for the treatment with N-acetyl-cysteine.
    Dröge W
    Pharmacology; 1993; 46(2):61-5. PubMed ID: 8441757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AIDS and lymphadenopathy syndrome (LAS) patients display similar abnormal in vitro proliferation and differentiation of T-colony forming cells (T-CFC).
    Lunardi Iskandar Y; Georgoulias V; Rozenbaum W; Vittecoq D; Meyer P; Gentilini M; Jasmin C
    Cancer Detect Prev Suppl; 1987; 1():525-33. PubMed ID: 3500783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A critical immunological and serological evaluation of patients with HTLV-III/LAV-related disorders.
    Sirianni MC; Luzi G; Mezzaroma I; Scano G; Ragona G; Soddu S; Ensoli B; Aiuti F
    Antibiot Chemother (1971); 1987; 38():141-50. PubMed ID: 2821880
    [No Abstract]   [Full Text] [Related]  

  • 24. [Zinc and lymphocyte subsets in patients with HIV infection].
    Libanore M; Bicocchi R; Raise E; Sighinolfi L; Bedetti A; Montanari P; Fagioli F; Benini A; Schiattone ML; Ghinelli F
    Minerva Med; 1987 Dec; 78(24):1805-12. PubMed ID: 2963239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma amino acid dysregulation after lentiviral infection.
    Dröge W; Murthy KK; Stahl-Hennig C; Hartung S; Plesker R; Rouse S; Peterhans E; Kinscherf R; Fischbach T; Eck HP
    AIDS Res Hum Retroviruses; 1993 Sep; 9(9):807-9. PubMed ID: 7903043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoregulatory defects associated with infection with the AIDS virus, HTLV-III.
    Crapper RM; Frazer IH; Mackay IR; Iscaro A; Bradford DL
    Concepts Immunopathol; 1987; 4():243-60. PubMed ID: 3297337
    [No Abstract]   [Full Text] [Related]  

  • 27. Plasma amino acid pattern of patients with HIV infection.
    Ollenschläger G; Jansen S; Schindler J; Rasokat H; Schrappe-Bächer M; Roth E
    Clin Chem; 1988 Sep; 34(9):1787-9. PubMed ID: 2901300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isotypes and IgG subclasses of anti-Fab antibodies in human immunodeficiency virus-infected hemophilia patients.
    Süsal C; Oberg HH; Daniel V; Dörr C; Terness P; Huth-Kühne A; Zimmermann R; Opelz G
    Vox Sang; 1994; 66(1):37-45. PubMed ID: 7908473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma fibronectin values in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex.
    Ogden DM; Fischer HE; Liu FJ; Rios A; Lichtiger B
    Am J Clin Pathol; 1988 Sep; 90(3):293-6. PubMed ID: 3414601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum prolactin concentrations in patients with the acquired immunodeficiency syndrome.
    Chernow B; Schooley RT; Dracup K; Napolitano LM; Stanford GG; Klibanski A
    Crit Care Med; 1990 Apr; 18(4):440-1. PubMed ID: 2318055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.
    Yarchoan R; Redfield RR; Broder S
    J Clin Invest; 1986 Aug; 78(2):439-47. PubMed ID: 3016028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased B lymphocyte ecto-5'nucleotidase and increased adenosine deaminase in mononuclear cells from patients infected with human immunodeficiency virus.
    Dalh Christensen L; Svenson M; Nygaard P; Andersen V; Faber V
    APMIS; 1988 Oct; 96(10):882-8. PubMed ID: 2847768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in plasma amino acid concentrations in response to HIV-1 infection.
    Hortin GL; Landt M; Powderly WG
    Clin Chem; 1994 May; 40(5):785-9. PubMed ID: 7909726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between HTLV-III neutralizing antibody and clinical status of pediatric acquired immunodeficiency syndrome (AIDS) and AIDS-related complex cases.
    Robert-Guroff M; Oleske JM; Connor EM; Epstein LG; Minnefor AB; Gallo RC
    Pediatr Res; 1987 Jun; 21(6):547-50. PubMed ID: 3474582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome.
    Lähdevirta J; Maury CP; Teppo AM; Repo H
    Am J Med; 1988 Sep; 85(3):289-91. PubMed ID: 3414726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of immunologic function in homosexual men with persistent, generalized lymphadenopathy and acquired immune deficiency syndrome.
    Burkes RL; Abo W; Levine AM; Linker-Israeli M; Parker JW; Gill PS; Krailo M; Horwitz DA
    Cancer; 1987 Feb; 59(4):731-8. PubMed ID: 3492262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heightened complement sensitivity of acquired immunodeficiency syndrome lymphocytes related to diminished expression of decay-accelerating factor.
    Lederman MM; Purvis SF; Walter EI; Carey JT; Medof ME
    Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4205-9. PubMed ID: 2471198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural killer activity from normal peripheral blood lymphocytes against a human T lymphotropic retrovirus type III (HTLV-III)-infected cell line.
    Sirianni MC; De Sanctis G; Macchi B; Soddu S; Ensoli F; Aiuti F; Fontana L
    Diagn Clin Immunol; 1988; 5(6):297-303. PubMed ID: 3219779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased CD1-positive cells in peripheral blood of AIDS and ARC patients.
    Chollet-Martin S; Pialoux G; Gougerot-Pocidalo MA
    Immunol Lett; 1988 Jan; 17(1):53-7. PubMed ID: 3258282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
    Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS
    J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.